Leonard E Egede1,2, Jennifer A Campbell3,4, Rebekah J Walker3,4, Aprill Z Dawson3,4, Joni S Williams3,4. 1. Division of General Internal Medicine, Department of Medicine, Medical College of Wisconsin, 701 Watertown Plank Rd, Milwaukee, WI, 53226-3596, USA. legede@mcw.edu. 2. Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, WI, USA. legede@mcw.edu. 3. Division of General Internal Medicine, Department of Medicine, Medical College of Wisconsin, 701 Watertown Plank Rd, Milwaukee, WI, 53226-3596, USA. 4. Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, WI, USA.
Abstract
BACKGROUND: Financial incentives is emerging as a viable strategy for improving clinical outcomes for adults with type 2 diabetes. However, there is limited data on optimal structure for financial incentives and whether financial incentives are effective in African Americans with type 2 diabetes. This pilot study evaluated impact of three financial incentive structures on glycemic control in this population. METHODS: Sixty adults with type 2 diabetes were randomized to one of three financial incentive structures: 1) single incentive (Group 1) at 3 months for Hemoglobin A1c (HbA1c) reduction, 2) two-part equal incentive (Group 2) for home testing of glucose andHbA1c reduction at 3 months, and 3) three-part equal incentive (Group 3) for home testing, attendance of weekly telephone education classes and HbA1c reduction at 3 months. The primary outcome was HbA1c reduction within each group at 3 months post-randomization. Paired t-tests were used to test differences between baseline and 3-month HbA1c within each group. RESULTS:The mean age for the sample was 57.9 years and 71.9% were women. Each incentive structure led to significant reductions in HbA1c at 3 months with the greatest reduction from baseline in the group with incentives for multiple components: Group 1 mean reduction = 1.25, Group 2 mean reduction = 1.73, Group 3 mean reduction = 1.74. CONCLUSION: Financial incentives led to significant reductions in HbA1c from baseline within each group. Incentives for multiple components led to the greatest reductions from baseline. Structured financial incentives that reward home monitoring, attendance of telephone education sessions, and lifestyle modification to lower HbA1c are viable options for glycemic control in African Americans with type 2 diabetes. TRIAL REGISTRATION: Trial registration: NCT02722499 . Registered 23 March 2016, url.
RCT Entities:
BACKGROUND: Financial incentives is emerging as a viable strategy for improving clinical outcomes for adults with type 2 diabetes. However, there is limited data on optimal structure for financial incentives and whether financial incentives are effective in African Americans with type 2 diabetes. This pilot study evaluated impact of three financial incentive structures on glycemic control in this population. METHODS: Sixty adults with type 2 diabetes were randomized to one of three financial incentive structures: 1) single incentive (Group 1) at 3 months for Hemoglobin A1c (HbA1c) reduction, 2) two-part equal incentive (Group 2) for home testing of glucose and HbA1c reduction at 3 months, and 3) three-part equal incentive (Group 3) for home testing, attendance of weekly telephone education classes and HbA1c reduction at 3 months. The primary outcome was HbA1c reduction within each group at 3 months post-randomization. Paired t-tests were used to test differences between baseline and 3-month HbA1c within each group. RESULTS: The mean age for the sample was 57.9 years and 71.9% were women. Each incentive structure led to significant reductions in HbA1c at 3 months with the greatest reduction from baseline in the group with incentives for multiple components: Group 1 mean reduction = 1.25, Group 2 mean reduction = 1.73, Group 3 mean reduction = 1.74. CONCLUSION: Financial incentives led to significant reductions in HbA1c from baseline within each group. Incentives for multiple components led to the greatest reductions from baseline. Structured financial incentives that reward home monitoring, attendance of telephone education sessions, and lifestyle modification to lower HbA1c are viable options for glycemic control in African Americans with type 2 diabetes. TRIAL REGISTRATION: Trial registration: NCT02722499 . Registered 23 March 2016, url.
Authors: Robert J Young; Jean Taylor; Tim Friede; Sally Hollis; James M Mason; Pauline Lee; Edna Burns; Andrew F Long; Tina Gambling; John P New; J Martin Gibson Journal: Diabetes Care Date: 2005-02 Impact factor: 19.112
Authors: Kevin G Volpp; Andrea B Troxel; Mark V Pauly; Henry A Glick; Andrea Puig; David A Asch; Robert Galvin; Jingsan Zhu; Fei Wan; Jill DeGuzman; Elizabeth Corbett; Janet Weiner; Janet Audrain-McGovern Journal: N Engl J Med Date: 2009-02-12 Impact factor: 91.245
Authors: Graham T McMahon; Helen E Gomes; Sara Hickson Hohne; Tang Ming-Jye Hu; Betty A Levine; Paul R Conlin Journal: Diabetes Care Date: 2005-07 Impact factor: 19.112
Authors: Eleni Mantzari; Florian Vogt; Ian Shemilt; Yinghui Wei; Julian P T Higgins; Theresa M Marteau Journal: Prev Med Date: 2015-04-02 Impact factor: 4.018
Authors: Leonard E Egede; Rebekah J Walker; Sebastian Linde; Jennifer A Campbell; Aprill Z Dawson; Joni S Williams; Mukoso N Ozieh Journal: Health Aff (Millwood) Date: 2022-06-27 Impact factor: 9.048